Teste masking pharmaceutical composition
OwnerPhillip John Ferguson, Charles Robert Hillierinventors
Life of this patent
Estimating the term…
Abstract
The invention describes a composition suitable for oral administration comprising and antibiotic macrolide and a polycarbophil. The antibiotic macrolide is preferably clarithromycin. The polycarbophil is reported to have surprising taste-masking properties in combination with the antibiotic and acts by inhibiting the undesirable release of the antibiotic component in the mouth or stomach. Several methods of preparing granules of the antibiotic macrolide said polycarbophil are also described.
Claims12
1 an oral pharmaceutical composition comprising a macrolide and a polycarbophil.
The oral pharmaceutical composition according to claim 1 wherein the macrolidc is selected from the group comprising eromycin A, crythromycin B, erythromycin C, erythromycin D, clarithromycin, dirithromycin, josamycin, midecamnycin, kitasamycin, tylosin, roxithromycin, rokitamycin, oleandomycin, miocamycin, flunthromycin, rosarmicin spiramycin and azithrornycin.
The oral pharmaceutical composition of claim 1 wherein the macrolide is clarithromycin.
A process for preparing granules of a macrolide and a polycarbophil comprising the steps of:
- (i) mixing a macrolidc and a polycarbophil in a weight ratio of macrolide to polycarbophil is between about 1:10 and about 5:1,
- (ii) wetting the mixture in a granulating solution,
- (iii) blending the wetted mixture for a time sufficient to form granules in a blender wherein the head space temperature is maintained at below 60° C., and
- (iv) drying and screening the resultant dried mass to form the desired macrolide-polycarbophil granules.
10 The process according to claim 9 further comprising a second granulation procedure, the procedure comprising the steps of:
- (v) sizing the dried granules prepared at step (iv) with a suitable binder solution such as a 10% aqueous polyvinyl pyrrolidone (PVP) K90, and
- (vi) drying and, milling or serving the dried mass to recover granules with a particle size of between 180μ and 710μ and optionally
- (vii) coating the granules with a suitable enteric coating.
Dependencies are inferred from the claim text.